ASCENDIS PHARMA A/S's ticker is ASND and the CUSIP is 04351P101. A total of 164 filers reported holding ASCENDIS PHARMA A/S in Q2 2023. The put-call ratio across all filers is 0.63 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $561,410,005 | +1.1% | 5,995,408 | -3.6% | 0.95% | +6.7% |
| Q2 2023 | $555,353,752 | -24.3% | 6,222,451 | -9.1% | 0.89% | -26.0% |
| Q1 2023 | $733,893,130 | -13.2% | 6,844,741 | -1.1% | 1.21% | -19.2% |
| Q4 2022 | $845,183,078 | +14.5% | 6,920,356 | -3.2% | 1.49% | +15.1% |
| Q3 2022 | $738,257,000 | +6.3% | 7,149,493 | -4.3% | 1.30% | +10.6% |
| Q2 2022 | $694,698,000 | -27.9% | 7,473,086 | -9.0% | 1.17% | -7.8% |
| Q1 2022 | $963,870,000 | -9.8% | 8,212,938 | +3.4% | 1.27% | +0.6% |
| Q4 2021 | $1,068,227,000 | -13.9% | 7,940,434 | +2.0% | 1.26% | -16.5% |
| Q3 2021 | $1,240,829,000 | +46.7% | 7,784,860 | +21.1% | 1.52% | +50.1% |
| Q2 2021 | $845,789,000 | +8.5% | 6,429,407 | +6.3% | 1.01% | +2.4% |
| Q1 2021 | $779,323,000 | -19.0% | 6,046,890 | +4.8% | 0.98% | -16.0% |
| Q4 2020 | $961,908,000 | +11.0% | 5,767,527 | +2.7% | 1.17% | -4.2% |
| Q3 2020 | $866,540,000 | +45.3% | 5,615,217 | +39.3% | 1.22% | +28.2% |
| Q2 2020 | $596,259,000 | +106.9% | 4,031,504 | +57.5% | 0.96% | +54.8% |
| Q1 2020 | $288,209,000 | -3.9% | 2,559,356 | +18.7% | 0.62% | +17.5% |
| Q4 2019 | $299,998,000 | +45.6% | 2,156,396 | +0.8% | 0.52% | +34.6% |
| Q3 2019 | $206,093,000 | +12.3% | 2,139,665 | +34.3% | 0.39% | +15.4% |
| Q2 2019 | $183,465,000 | +37.8% | 1,593,267 | +40.9% | 0.34% | +28.5% |
| Q1 2019 | $133,131,000 | +479.1% | 1,131,107 | +208.2% | 0.26% | +405.8% |
| Q4 2018 | $22,989,000 | +40.0% | 366,947 | +58.4% | 0.05% | +67.7% |
| Q3 2018 | $16,416,000 | +183.3% | 231,672 | +166.0% | 0.03% | +158.3% |
| Q2 2018 | $5,795,000 | – | 87,111 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RA Capital Management | 7,387,900 | $1,177,557,000 | 16.32% |
| Q Global Advisors, LLC | 66,714 | $10,634,000 | 8.85% |
| Ghost Tree Capital, LLC | 120,000 | $19,127,000 | 5.59% |
| Vivo Capital, LLC | 760,606 | $121,233,000 | 5.44% |
| Spyglass Capital Management LLC | 1,378,887 | $219,781,000 | 5.04% |
| Avoro Capital Advisors LLC | 1,980,000 | $315,592,000 | 4.96% |
| Eversept Partners, LP | 445,203 | $70,960,906 | 4.93% |
| Sofinnova Investments, Inc. | 499,824 | $79,667,000 | 4.72% |
| Eventide Asset Management | 1,748,648 | $278,717,000 | 3.68% |
| Baker Brothers Advisors | 4,541,604 | $723,886,000 | 3.18% |